Search Results - "Fuentes, Javier David Benitez"

Refine Results
  1. 1

    The Missed Opportunity: HIV, Hepatitis C Virus (HCV), and Hepatitis B Virus (HBV) Positive Patients in Neoadjuvant and Perioperative Immunotherapy Clinical Trials for Lung Cancer by Benitez Fuentes, Javier David

    Published in Curēus (Palo Alto, CA) (29-12-2023)
    “…This editorial addresses a critical oversight in recent clinical trials on neoadjuvant or perioperative immunotherapy for lung cancer, the exclusion of…”
    Get full text
    Journal Article
  2. 2

    Achieving complete metabolic response in stage IV lung adenocarcinoma with chemotherapy, nivolumab, ipilimumab, and salvage SBRT: A case report by Gamez Casado, Salvador, Benitez Fuentes, Javier David, Álvarez Rodríguez, Beatriz, García Ledo, Gema

    Published in Respirology case reports (01-04-2024)
    “…Oncogene-negative, PDL1-negative metastatic non-small cell lung cancer (NSCLC) presents significant treatment challenges due to its complexity and resistance…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Perforation of the Nasal Septum in a Colorectal Cancer Patient Treated With Aflibercept: A Case Report by Benitez Fuentes, Javier David, Lopez de Sa Lorenzo, Alfonso, Calvo Elias, Alberto Elpidio, Toledano Rojas, Carmen, Granja Ortega, Monica

    Published in Curēus (Palo Alto, CA) (12-07-2022)
    “…Aflibercept is an antiangiogenic agent used in patients with metastatic colorectal cancer who have progressed to a first-line oxaliplatin-based regimen. The…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Prognostic value of human leukocyte antigen G expression in solid tumors: a systematic review and meta-analysis by Bartolome, Jorge, Molto, Consolacion, Benitez-Fuentes, Javier David, Fernandez-Hinojal, Gonzalo, Manzano, Aranzazu, Perez-Segura, Pedro, Mittal, Abhenil, Tamimi, Faris, Amir, Eitan, Ocana, Alberto

    Published in Frontiers in immunology (18-05-2023)
    “…Identification of modulators of the immune response with inhibitory properties that could be susceptible for therapeutic intervention is a key goal in cancer…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Prognostic value of human leukocyte antigen G (HLA-G) expression in solid tumors: A systematic review and meta-analysis by Bartolome, Jorge, Molto, Consolacion, Benitez Fuentes, Javier David, Fernández-Hinojal, Gonzalo, Manzano, Aránzazu, Perez Segura, Pedro, Mittal, Abhenil, Tamimi, Faris, Amir, Eitan, Ocana, Alberto

    Published in Journal of clinical oncology (01-06-2023)
    “…e14639 Background: Identification of modulators of the immune response with inhibitory properties that could be susceptible for therapeutic intervention is a…”
    Get full text
    Journal Article
  15. 15

    High-grade neuroendocrine head and neck cancer: Case series and review of the literature by Fuentes, Javier David Benitez, Fouda, Sally, Evans, Elin, Palaniappan, Nachi, Rackley, Thomas, Chan, Po, Evans, Mererid, Webster, Richard

    Published in Current problems in cancer (01-08-2024)
    “…High-grade neuroendocrine cancers (NEC) of the head and neck (HN) are rare and aggressive, accounting for ≤1 % of all HN cancers, with a 5-year overall…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Achieving complete metabolic response in stage IV lung adenocarcinoma with chemotherapy, nivolumab, ipilimumab, and salvage SBRT: A case report by Gamez Casado, Salvador, Benitez Fuentes, Javier David, Álvarez Rodríguez, Beatriz, García Ledo, Gema

    Published in Respirology case reports (01-04-2024)
    “…Oncogene-negative, PDL1-negative metastatic non-small cell lung cancer (NSCLC) presents significant treatment challenges due to its complexity and resistance…”
    Get full text
    Report